Articles tagged "Liver cirrhosis"

2020 American Transplant Congress
Frailty Prior to Hospital Discharge Predicts Mortality after Cirrhosis-Related Admissions
M. Serper¹, S. Tao², P. Garren¹, D. Peyton¹, M. A. Dunn², K. Reddy¹, A. Gougol², A. Duarte-Rojo²
¹University of Pennsylvania, Philadelphia, PA, ²University of Pittsburgh, Pittsburgh, PA
*Purpose: Inpatient frailty assessment and its utility in clinical care is understudied in liver transplant (LT) candidates. Study objectives were to quantify physical frailty among…
2020 American Transplant Congress
Left Lobe Living Donor Liver Transplantation Using Rapid Procedure in a Cirrhotic Patient with Hepatocellular Carcinoma with a GRWR of 0.35
D. Balci¹, O. Kirimker¹, M. Kologlu², U. Goktug¹, E. Ustuner³, S. Karadag⁴, E. Er⁵, G. Cinar⁶, M. Bayar⁴, A. Yilmaz⁴, A. Azap⁶, K. Karayalcin¹
¹General Surgery and Transplantation, Ankara University, Ankara, Turkey, ²Pediatric Surgery and Transplantation, Ankara University, Ankara, Turkey, ³Radiology, Ankara University, Ankara, Turkey, ⁴Anesthesiology, Ankara University, Ankara, Turkey, ⁵Gastroenterology, Ankara University, Ankara, Turkey, ⁶Infectious Disease, Ankara University, Ankara, Turkey
*Purpose: Here, we describe a new approach using Rapid Procedure, a 2 stage hepatectomy technique, with living donor liver transplantation (LDLT) in the cirrhotic setting…
2020 American Transplant Congress
Characterization of Gut Microbiome in Liver Transplant Recipients with Non-Alcoholic Steatohepatitis
S. Sataphaty¹, P. Banerjee², J. Pierre³, R. Heda³, S. Dutta³, D. D. Higgins⁴, V. Mas⁵, S. Khan⁶, V. Mupparaju³, S. R. Nair⁷, J. D. Eason⁸, D. Kleiner⁹, D. Maluf¹⁰
¹Department of Surgery, Division of Hepatology and Sandra Atlas Bass Center for Liver Diseases, Northwell Health, NYC, NY, ²School of Public Health, University of Memphis, Memphis, TN, ³University of Tennessee Health Science Center, Memphis, TN, ⁴University of Memphis, Memphis, TN, ⁵James D Eason Transplant Institute, Memphis, TN, ⁶Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NYC, NY, ⁷Department of Surgery, James D Eason Transplant Institute, Memphis, TN, ⁸Department of Surgery, James D Eason Transplant Institute, NYC, TN, ⁹Laboratory of Pathology/National Cancer Institute, Bethesda, WA, ¹⁰Department of Surgery_ University of Tennessee, James D Eason Transplant Institute, NYC, TN
*Purpose: Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) is a growing problem globally and recurs even after liver transplant (LT).…
2020 American Transplant Congress
Bedside Ultrasound to Assess for Sarcopenia in Cirrhotic Patients Undergoing Inpatient Liver Transplant Evaluation
M. Aguilar¹, E. A. Rodriguez¹, A. Andrekus², S. Buckner-Petty², N. Dahiya², E. J. Carey²
¹GI/Hepatology, Mayo-Arizona, Scottsdale, AZ, ²Mayo-Arizona, Scottsdale, AZ
*Purpose: Sarcopenia is routinely assessed during outpatient evaluation for liver transplant (LT) candidacy in cirrhotic patients as it is associated with poor clinical outcomes. Skeletal…
2020 American Transplant Congress
Using Nudges for Liver Transplantation Prehabilitation: Results from PRIMER (Prehabilitation Intervention to Maximize Early Recovery), a Home-Based Behavioral Pilot and Feasibility Trial
M. Serper, L. S. Jones, T. Clement, K. Reddy, A. Duarte-Rojo, P. P. Reese
University of Pennsylvania, Philadelphia, PA
*Purpose: Data on effective prerehabilitation in liver transplant (LT) is limited. We studied the feasibility and acceptability of a pilot randomized controlled trial of a…
2020 American Transplant Congress
The Therapeutic Potential of Human Liver-Derived Stem Cells Transplantation in Carbon Tetrachloride-Induced Rat Liver Cirrhotic Model
S. Lee¹, J. Lee², H. Park², Y. Kim², S. Lee¹
¹Department of Surgery, Samsung Medical Center, Seoul, Korea, Republic of, ²Stem Cell and Regenerative Medicine Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Cirrhosis is a long-term consequence of chronic hepatic injury and there are no effective treatment methods. Mesenchymal stem cells (MSCs) have been reported to…
2019 American Transplant Congress
The Impact of Sleeve Gastrectomy Following Liver Transplant in Patients with Non-Alcoholic Steatosis: A Five-Year Experience
M. C. Morris¹, A. D. Jung¹, Y. Kim¹, V. K. Dhar¹, S. Shah¹, D. Schauer², E. Smith², T. Diwan¹
¹Surgery, University of Cincinnati, Cincinnati, OH, ²Medicine, University of Cincinnati, Cincinnati, OH
*Purpose: Non-alcoholic steatohepatitis (NASH) cirrhosis is an increasingly common indication for liver transplantation (LT) in the United States and obese patients continue to be at…
2019 American Transplant Congress
Gender Disparities In Cirrhosis: New Findings In A Large Pretransplant Population
N. Mazumder, K. Atiemo, A. Daud, L. Zhao, M. Abecassis, J. Levitsky, D. P. Ladner
Northwestern Memorial Hospital, Chicago, IL
*Purpose: There is concern that female patients may suffer worse outcomes than their male counterparts while awaiting liver transplant. Studies on this topic often use…
2019 American Transplant Congress
Early Impact of the New United Network for Organ Sharing Simultaneous Liver-Kidney Transplantation Allocation Policy: Improved Standardization but Similar Utilization
G. Cullaro¹, E. C. Verna², J. C. Lai¹
¹UCSF, San Francisco, CA, ²Columbia University, New York, NY
*Purpose: In an effort to standardize SLKT utilization, UNOS/OPTN implemented a new SLKT policy on August 10th, 2017. We aimed to characterize the early impact…
2019 American Transplant Congress
Increasing Incidence and Transplantation of Individuals Listed with Alcoholic Liver Disease
E. L. Godfrey¹, A. Rana², J. A. Goss²
¹Department of Student Affairs, Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: Alcoholic liver disease (ALD) has recently become the most common indication for liver transplantation in the US; it is important to characterize changes in…

« Previous Page
1
…
5
6
7
8
9
…
14
Next Page »